| GeneLibs

题目:: Update of research on the role of EZH2 in cancer progression.
作者:: Shen(Liang),Cui(Jing),Liang(Shumei),Pang(Yingxin),Liu(Peishu)
状态:: 发布时间2013-04-16 , 更新时间 2013-04-19
期刊:: Onco Targets Ther
摘要:: Accumulating evidence shows that enhancer of zeste homolog 2 (E2H2) is upregulated in a broad range of cancer types, such as breast cancer, prostate cancer, ovarian cancer, and colon cancer. Therefore, inhibiting EZH2 expression may be a promising strategy for anticancer therapy. This review focuses on the current understanding of the mechanisms underlying EZH2 regulation that are involved in cancer progression. Also, it introduces two EZH2 inhibitors that target EZH2 and could be potentially applied in the treatment of cancer in the future.
语言:: eng
DOI:

文献库文献相关信息